Calcort Tab. 6mg

Ingredient

Deflazacort (Micronized)

Content

6mg

Indication

1) rheumatoid disorders and connective tissue diseases: Maintenance therapy and treatment of acute exacerbation of psoriatic arthritis and rheumatoid arthritis, which are ineffective with general treatment, polymyalgia rheumatic, acute rheumatic fever, systemic lupus erythematosus, cranial arteritis, and Wegener’s granulomatosis
2) skin diseases: Pemphigus, bullous pemphigoid, exfoliative dermatitis, erythema multiforme, erythema nodosum, and severe psoriasis
3) allergic diseases: Bronchial asthma, which is not effective with general treatment
4) respiratory diseases: Sarcoidosis with pulmonary infiltration, extrinsic allergic alveolitis (silicosis due to organic dust), desquamative interstitial pneumonia (idiopathic pulmonary fibrosis)
5) ophthalmic diseases: Choroiditis, chorioretinitis, iritis, and iridocyciltis
6) hematopoietic system diseases: Idiopathic thrombocytopenia, hemolytic anemia, lymphatic leukemia, and lymphoma
7) gastrointestinal diseases: Ulcerative colitis and Crohn’s disease
8) liver disease: Chronic active hepatitis (autoimmune hepatitis)
9) kidney disease: Nephrotic syndrome